Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
CH3(CH2)7CH=CH(CH2)7COOH
CAS Number:
Molecular Weight:
282.46
EC Number:
204-007-1
UNSPSC Code:
12352106
PubChem Substance ID:
Beilstein/REAXYS Number:
1726542
MDL number:
Assay:
≥70.0%
Form:
liquid
Grade:
SAJ first grade
grade
SAJ first grade
vapor pressure
1 mmHg ( 176 °C)
assay
≥70.0%
form
liquid
availability
available only in Japan
refractive index
n20/D 1.459 (lit.)
bp
194-195 °C/1.2 mmHg (lit.)
mp
13-14 °C (lit.)
density
0.89 g/mL at 25 °C (lit.)
functional group
oleic acid
storage temp.
room temp
SMILES string
CCCCCCCC\C=C/CCCCCCCC(O)=O
InChI
1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9-
InChI key
ZQPPMHVWECSIRJ-KTKRTIGZSA-N
Still not finding the right product?
Explore all of our products under Oleic acid
Storage Class
10 - Combustible liquids
wgk
WGK 1
ppe
Eyeshields, Gloves, type ABEK (EN14387) respirator filter
flash_point_f
>235.4 °F - closed cup
flash_point_c
> 113 °C - closed cup
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Marta Estrader et al.
Nanoscale, 7(7), 3002-3015 (2015-01-21)
The intimate relationship between stoichiometry and physicochemical properties in transition-metal oxides makes them appealing as tunable materials. These features become exacerbated when dealing with nanostructures. However, due to the complexity of nanoscale materials, establishing a distinct relationship between structure-morphology and
Stefan Freigang et al.
Nature immunology, 14(10), 1045-1053 (2013-09-03)
Chronic inflammation is a fundamental aspect of metabolic disorders such as obesity, diabetes and cardiovascular disease. Cholesterol crystals are metabolic signals that trigger sterile inflammation in atherosclerosis, presumably by activating inflammasomes for IL-1β production. We found here that atherogenesis was
Ying Liu et al.
American journal of physiology. Renal physiology, 305(11), F1555-F1562 (2013-08-16)
Diabetic nephropathy (DN) is a leading cause of end-stage renal disease (ESRD). The inhibitors of renin-angiotensin-aldosterone system (RAAS) can alleviate some of the symptoms of DN but fail to stop the progression to ESRD. Our previous studies demonstrate renoprotective action